Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New mu opioid receptor ligands disclosed in recent Progenics patent

June 25, 2008

NeuroSearch reports positive results from a phase II study in adult ADHD

June 23, 2008

FDA lifts clinical hold on AeroLEF and clears phase II clinical trial

June 23, 2008

SUVN-502 enters phase I trials for Alzheimer's disease

June 20, 2008

Hisamitsu and Kyowa enter joint sales agreement in Japan for HFT-290 for cancer pain

June 19, 2008

Pivotal phase III Acurox trial meets primary endpoint

June 19, 2008

Cipher's revised CIP-Tramadol ER NDA accepted for review by the FDA

June 19, 2008

New agents for treating neurological disorders disclosed in recent NeuroSearch and reMYND patents

June 19, 2008

Takeda requests reexamination of negative opinion for ramelteon given by EMEA's CHMP

June 18, 2008

Elan and Wyeth present top-line results from phase II bapineuzumab trial in AD

June 18, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...